Literature DB >> 29141824

Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis.

Celia Oreja-Guevara1, Ulises Gómez-Pinedo2, Julia García-López3, Rafael Sánchez-Sánchez4, Roberto Valverde-Moyano5, Alberto Rabano-Gutierrez6, Jordi A Matías-Guiu7, Ines González-Suárez8, Jorge Matías-Guiu9.   

Abstract

INTRODUCTION: Neural stem cells (NSC) are located essentially in the subventricular zone (SVZ), subgranular zone (SGZ), and along the central canal of the spinal cord. These cells can proliferate in vitro and differentiate into neurons, oligodendrocytes, and astroglia, thus contributing to repair in multiple sclerosis (MS). We conducted a pathological study to analyse neurogenic response in a patient with Marburg variant MS.
METHODS: We present the case of a 27-year-old immunocompetent patient with Marburg variant MS, a fulminant form of the disease. The condition lasted 20 days. Diagnosis was based on clinical symptoms and MRI showed demyelinating lesions located in subependymal areas and histopathological findings. Neurogenic niches (SVZ and dentate gyrus) were analysed by confocal microscopy using markers of proliferation (Ki-67, PCNA), neuroblasts (PSA-NCAM, DCX, Tuj1), stem cells (Nestin, GFAPδ, SOX2, PAX6, Musashi), astrocytes (GFAP, AQ4), oligodendrocytes (NG2, Olig), microglia and cell infiltrates (IBA-1, CD68, MHCII), and cell death (TUNEL).
RESULTS: Expression of the markers GFAPδ, SOX2, and PAX6 in NSC was found to be very low. Likewise, markers of proliferation (Ki-67) and intermediate precursors (NG2) were also reduced. This lack of markers of the first stages of cell differentiation means that neurogenesis is inhibited even in very early stages of the disease.
CONCLUSION: Inhibition of neurogenesis in our patient, which cannot be explained by the fulminant nature of his symptoms, may be related to inflammation and immune response. This finding may further our knowledge of repair mechanisms in MS.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adult neurogenesis; Marburg variant; Multiple sclerosis; SVZ

Mesh:

Year:  2017        PMID: 29141824     DOI: 10.1016/j.msard.2017.09.024

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  2 in total

1.  Anti-Myelin Proteolipid Protein Peptide Monoclonal Antibodies Recognize Cell Surface Proteins on Developing Neurons and Inhibit Their Differentiation.

Authors:  Raymond A Sobel; Mary Jane Eaton; Prajakta Dilip Jaju; Eugene Lowry; Julian R Hinojoza
Journal:  J Neuropathol Exp Neurol       Date:  2019-09-01       Impact factor: 3.685

2.  Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A.

Authors:  Victor Oliveira Araújo; Paulo Filho Soares Marcelino; Samuel Ramos Rabelo; Fabio Antonio Serra de Lima Junior; Vitor Gil Gonçalves Teixeira; Roberto Rocha Eisele; Afonso Rocha Eisele; João Pedro Serenario Ferreira de Carvalho; Luciano Barroso de Albuquerque Filho; Sara Diógenes Peixoto de Medeiros; Leandro Freitas Oliveira; Julio Cesar Claudino Dos Santos; Euldes Mendes Júnior
Journal:  Radiol Case Rep       Date:  2022-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.